Tatiana H. G.
- Country
- Spain
- Department
- Oncology
Research Overview
- Pharmacokinetic and Safety Evaluation of Oral Decitabine and Cedazuridine in Patients with Solid Tumors, Myelodysplastic Syndrome, or Acute Myeloid Leukemia with Hepatic Impairment
- Phase I Clinical Trial of TOS-358 in Adult Patients with Advanced Solid Tumors: Colorectal, Cervical, Endometrial, Gastric, Urothelial, Breast, Head and Neck, Ovarian, and NSCLC.
- Pharmacokinetic and Safety Evaluation of Oral Decitabine and Cedazuridine in Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Solid Tumors with Renal Impairment
Data & Insights
Has run more than one trial at 139 of 239 partner sites.
Specializations
Solid Tumor Oncology
Focus on a broad spectrum of solid tumors including gastrointestinal, thoracic, and gynecologic cancers.
- Colorectal cancer
- Non‑Small Cell Lung Cancer
- Breast cancer
- Ovarian cancer
- Gastric cancer
Encompasses both early‑stage and advanced disease settings.
Hematologic Malignancies
Investigates malignant disorders of the blood and bone marrow such as acute myeloid leukemia and related syndromes.
- Acute myeloid leukemia
- Myelodysplastic syndrome
- Chronic myelomonocytic leukemia
Includes studies of high‑risk and relapsed disease.
Targeted Molecular Oncology
Explores therapies directed at specific genetic alterations like KRAS G12C, HER2, and SMARCA4 mutations.
- KRAS‑mutated tumors
- HER2‑positive cancers
- SMARCA4‑deficient malignancies
- PIK3CA‑mutated solid tumors
- MTAP‑deleted cancers
Emphasizes precision medicine approaches.
Pain and Symptom Management
Addresses chronic pain conditions associated with cancer and non‑cancer etiologies, including diabetic peripheral neuropathic pain and knee osteoarthritis pain.
- Neuropathic pain
- Osteoarthritis pain
- Cancer‑related pain
Evaluates patient‑reported outcomes and quality of life.
Infectious Disease Immunology
Conducts studies on immune responses to viral pathogens, notably COVID‑19 vaccine boosters.
- SARS‑CoV‑2 vaccine efficacy
- Neutralising antibody responses
- Variant‑specific immunogenicity
Integrates immunogenicity assessments with safety monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.